Navigation Links
Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Date:2/1/2008

ALLEGAN, Mich., Feb. 1 /PRNewswire-FirstCall/ -- The Perrigo Company (Nasdaq: PRGO; TASE) today announced that the Board of Directors has authorized the repurchase of $150 million of the Company's common stock through February 1, 2010 under its ongoing share repurchase program. Any remaining balance of the previously authorized program will expire on February 8, 2009. Under share repurchase programs since November 2000, Perrigo has repurchased 11.4 million shares at a cost of approximately $174 million. As of January 25, 2008, Perrigo had 93,080,386 common shares outstanding.

The Company also announced that its Board of Directors declared a quarterly dividend of $0.05 per share, payable on March 18, 2008 to shareholders of record on February 22, 2008.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).


'/>"/>
SOURCE The Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
2. Perrigo Company to Host Analyst Meeting on September 18, 2007
3. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
4. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1, 2007
7. Perrigo Company Announces Dividend Increase
8. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
9. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
10. Perrigo Acquires UK OTC Store Brand Supplier
11. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)... Dec. 1 Medication therapy managem...ccomplished professionals to its,advisory board. ... include Martin Makary, M.D.;,Michael Burcham; an... of,advisors that has helped PharmMD launch and h... medication error, misuse, overuse and abuse. MTM...
(Date:12/1/2008)...Dec. 1 The United State...is new right hand on Saturday, November 29, as Dr....on, changed the bandages. , , "Wow, it look...from his room at Jewish Hospital. "It,s awesome,"... , Hondusky, a New York resident, went on to ...
(Date:12/1/2008)...he implant makes it more difficult to treat the ma...c. 1 (HealthDay News) -- Women who have had their ...nosed with early-stage breast cancer may be treate...atment known as brachytherapy, according to an Ari...hallenge to take care of these augmented women," s...
(Date:12/1/2008)...Dec. 1 /PRNewswire-USNewswire/ -- As part of the...tary of Health Everette James today urged Pennsylv...s AIDS. He also highlighted ongoing efforts to edu...evented. , , "Our message is clear: regardl... race, being tested for HIV is the only sure way t...
Breaking Medicine News(10 mins):Health News:PharmMD Expands Advisory Board 2Health News:Fifth U.S. Hand Transplant Patient Gets Look at New Hand 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2
...hers the appropriate treatment should be recommend...uce the complications. Women who have// had breast...ose who have chemotherapy and tamoxifen may have r...niversity of Cleavland report on one of the larges...
... had approved Elidel ( pimecrolimus ) cream for tr...n called atopic dermatitis, or eczema. The skin co... rashes that often seep and ooze. The drug maker, ...eople in the U.S. develop flare-ups of eczema. // ...
...tudy a diet high in animal products raises the ris...s protection. Many studies have suggested a link b...nd breast cancer.// An independent researcher base...es might explain the geographical variation in bre...
... easy painfree way to detect oral cancer at its ea...ich underwent clinical trials at the University of...ed it to be a significant advance over previous cy...g to Martin S. Greenberg, professor and chairman o...
Other Medicine News:
(Date:11/27/2008)... New study finds the majority of acute lymphoblas...dy present at the time of diagnosis , , MEM...ientists at St. Jude Children,s Research Hospital ... cancer cells of children with acute lymphoblastic...fers a pathway to designing treatments for ALL rel...
(Date:11/25/2008)... LOUISVILLE, Ky., Nov. 25 /PRNewswire-USNewswire/...and surgeons performed the fifth U.S. hand transpl...usky, at Louisville,s Jewish Hospital Hand Care Ce...dure began around noon and was completed shortly a...oto: http://www.newscom.com/cgi-bin/prnh/2008112...
(Date:11/25/2008)... 200 Patients Enrolled in Clinical Trial to Asses...ard of Care Therapies for Unresectable Hepatocellu... Light Sciences Oncology, Inc. (LSO...a global Phase 3 clinical trial of Light Infusion ...able hepatocellular carcinoma (HCC), also known as...
(Date:11/24/2008)... november is Pancreatic Cancer Awareness Month ,...wswire/ -- The American Society for Gastrointesti...ion Network are teaming up this November to raise ...nts about the disease and the resources that are a... the fourth leading cause of cancer deaths in the ...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 12032 1McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 12032 2Hypoglycemia Alert Dogs Offer Assistance to People with Diabetes 12029 1Hypoglycemia Alert Dogs Offer Assistance to People with Diabetes 12029 2Hypoglycemia Alert Dogs Offer Assistance to People with Diabetes 12029 3CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference 12026 1CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference 12026 2Viral Therapy Slows Pediatric Tumors in Mice 12024 1Viral Therapy Slows Pediatric Tumors in Mice 12024 2
...ption Pain,Reliever to Health Care Professionals ...nd Drug,Administration,s (FDA) Office of Criminal ...ue Frederick Company, Inc. has agreed,to pay more ...civil,liabilities in connection with several illeg...a powerful prescription pain reliever,that the com...
...Innovations and a Health Conscious,Public?, WASHIN...e Food,and Drug Administration (FDA) must adapt to...althcare, Commissioner Andrew von,Eschenbach told ...h,Annual Conference April 12 in Bethesda, Md. , FD...mited,financial and personnel resources to deal wi...
Other Medicine Technology:FDA Announces Results of Investigation Into Illegal Promotion of,OxyContin by The Purdue Frederick Company, Inc. 2FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: